Active Ingredient: GLATIRAMER ACETATE
Proprietary Name: GLATIRAMER ACETATE
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: 40MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A206936
Product Number: 001
Approval Date: Oct 3, 2017
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
